Moderna Co-founder and Chairman Noubar Afeya discussing vaccine boosters on Bloomberg technology.
“We need to be able to keep the antibody levels high and we need to be able to track them.”
From the recent Investor conference, Access Bio have a number of Antibody containers in process and Atomo seem comfortable with their relationship which may expand.
Antibodies provide critical information which determines immunity.
Media Update, page-726
-
- There are more pages in this discussion • 1,120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
